March 24, 2020
FDA OKs Pfizer’s SNDA for expanded indication of EUCRISA ointment, 2%, in children as young as 3 months of age with mild-to-moderate atopic dermatitis
EUCRISA is the first and only 100% steroid-free, topical prescription medication approved for patients as young as 3 months of…